News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week in Review: Stryker Corporation  (SYK) Pays $764 Million for China Orthopedic Maker



1/22/2013 10:27:06 AM

by Richard Daverman, PhD

January 19, 2013 -- Stryker Corporation of the US will acquire a China orthopedic maker, Trauson Holdings, for $764 million in cash; Sanjiu Medical & Pharma acquired a 97% interest in Guilin Tianhe Pharma, an OTC patch products company; China National Biotec, the largest biotech in China, is reported to be planning a $1.5 billion Hong Kong IPO; Yunnan Walvax Biotech paid $49.2 million to acquire a 58% stake in Shanghai Zerun Biotech; Nanjing Micro-Tech, a medical device maker, received an equity investment from Actis; China’s SFDA is considering -reaching changes to its drug approval that will prioritize innovative drugs; Shenzhen Neptunus Bioengineering filed an application for a US Phase II clinical trial of Polydatin Injection; and Sihuan Pharma received SFDA approval to begin producing an opioid receptor inhibitor. More details….

Stock Symbols: (NYSE: SYK) (HK: 0325) (SHE: 000999) (SHE: 300142) (SHE: 000078) (HK: 0460)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES